Ethics approval
An informed consent was obtained from each patient and the Declaration of Helsinki was followed throughout the studies. The Committee for Medical Research Ethics of Health Region IV, Norway and The Norwegian Medicines Agency approved the studies (project numbers: 51–2000 and 145.04) and the supplement application for the current study (reference number 2010/3115 (145-04)). The clinical trials were registered at 